PepGen Inc (PEPG)
17.25
-0.23
(-1.32%)
USD |
NASDAQ |
Jun 14, 16:00
17.31
+0.06
(+0.35%)
After-Hours: 20:00
PepGen Cash from Investing (Quarterly): -11.29M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -11.29M |
| December 31, 2023 | -29.59M |
| September 30, 2023 | -0.225M |
| June 30, 2023 | -1.009M |
| March 31, 2023 | -1.181M |
| December 31, 2022 | -1.102M |
| September 30, 2022 | -0.43M |
| Date | Value |
|---|---|
| June 30, 2022 | -0.609M |
| March 31, 2022 | -1.614M |
| December 31, 2021 | -0.156M |
| September 30, 2021 | -0.024M |
| June 30, 2021 | -0.015M |
| March 31, 2021 | -0.305M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-29.59M
Minimum
Dec 2023
-0.015M
Maximum
Jun 2021
-3.658M
Average
-0.609M
Median
Jun 2022
Cash from Investing (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | -0.199M |
| Vertex Pharmaceuticals Inc | -2.136B |
| Sarepta Therapeutics Inc | 218.80M |
| PTC Therapeutics Inc | -114.93M |
| Regenxbio Inc | 13.18M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -22.53M |
| Cash from Financing (Quarterly) | 86.97M |
| Free Cash Flow | -77.58M |
| Free Cash Flow Per Share (Quarterly) | -0.7881 |
| Free Cash Flow Yield | -17.98% |